Suven Life Sciences Limited Stock NSE India S.E.
Equities
SUVEN
INE495B01038
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.4 INR | -0.81% | +6.15% | +36.78% |
Sales 2022 | 120M 1.43M | Sales 2023 | 136M 1.63M | Capitalization | 10.57B 127M |
---|---|---|---|---|---|
Net income 2022 | -1.22B -14.61M | Net income 2023 | -1.18B -14.17M | EV / Sales 2022 | 109 x |
Net cash position 2022 | 472M 5.66M | Net cash position 2023 | 2.27B 27.16M | EV / Sales 2023 | 61.1 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-7.31
x | Employees | 132 |
Yield 2022 |
1.08% | Yield 2023 |
-
| Free-Float | 28.95% |
Latest transcript on Suven Life Sciences Limited
1 day | -0.81% | ||
1 week | +6.15% | ||
Current month | +10.45% | ||
1 month | +10.45% | ||
3 months | +5.44% | ||
6 months | +75.46% | ||
Current year | +36.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 89-03-08 | |
M. Mohan Kumar
DFI | Director of Finance/CFO | - | 20-01-09 |
Shrenik Soni
CMP | Compliance Officer | - | 20-01-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 89-03-08 | |
Sudha Rani Jasti
FOU | Founder | 70 | 89-03-08 |
Director/Board Member | 70 | 10-04-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 110.4 | -0.81% | 109,193 |
24-04-29 | 111.4 | -0.09% | 147,183 |
24-04-26 | 111.4 | -1.89% | 169,884 |
24-04-25 | 113.6 | +1.02% | 558,699 |
24-04-24 | 112.4 | +5.00% | 236,641 |
Delayed Quote NSE India S.E., April 30, 2024 at 07:42 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.43% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.38% | 24.63B | |
-23.58% | 18.2B | |
+26.32% | 12.01B | |
-3.35% | 11.76B | |
+12.45% | 10.4B | |
-4.33% | 9.94B |
- Stock Market
- Equities
- SUVEN Stock
- SUVEN Stock